National Cancer Institute common terminology criteria for adverse events

Known as: Common Toxicity Criteria for Adverse Events, Common Toxicity Criteria, CTCAE Grades 
A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Precision medicine and personalized medicine are based on the development of biomarkers, and liquid biopsy has been reported to… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2017
Review
2017
Pharmacological and cellular treatment of cancer is changing dramatically with benefits for patient outcome and comfort, but also… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
IMPORTANCE To integrate the patient perspective into adverse event reporting, the National Cancer Institute developed a patient… (More)
Is this relevant?
2013
2013
The National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO… (More)
  • table 1
  • table 1
  • table 1
  • table 2
  • figure 1
Is this relevant?
Review
2011
Review
2011
Circulating tumor cells (CTCs) shed from primary and metastatic cancers are admixed with blood components and are thus rare… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Rare circulating tumor cells (CTCs) present in the bloodstream of patients with cancer provide a potentially accessible source… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND In cancer treatment trials, the standard source of adverse symptom data is clinician reporting by use of items from… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
PURPOSE In a previous study of treatment for advanced colorectal cancer, the LV5FU2 regimen, comprising leucovorin (LV) plus… (More)
Is this relevant?
Review
2000
Review
2000
In 1997, the National Cancer Institute (NCI) led an effort to revise and expand the Common Toxicity Criteria (CTC) with the goal… (More)
Is this relevant?